19-15052242-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_012114.3(CASP14):c.-10C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000313 in 1,587,734 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0018 ( 1 hom., cov: 31)
Exomes 𝑓: 0.00016 ( 1 hom. )
Consequence
CASP14
NM_012114.3 5_prime_UTR
NM_012114.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.121
Genes affected
CASP14 (HGNC:1502): (caspase 14) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This caspase has been shown to be processed and activated by caspase 8 and caspase 10 in vitro, and by anti-Fas agonist antibody or TNF-related apoptosis inducing ligand in vivo. The expression and processing of this caspase may be involved in keratinocyte terminal differentiation, which is important for the formation of the skin barrier. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 19-15052242-C-T is Benign according to our data. Variant chr19-15052242-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3045450.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASP14 | NM_012114.3 | c.-10C>T | 5_prime_UTR_variant | 2/7 | ENST00000427043.4 | NP_036246.1 | ||
CASP14 | XM_011527861.2 | c.-10C>T | 5_prime_UTR_variant | 2/6 | XP_011526163.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CASP14 | ENST00000427043 | c.-10C>T | 5_prime_UTR_variant | 2/7 | 1 | NM_012114.3 | ENSP00000393417.2 |
Frequencies
GnomAD3 genomes AF: 0.00178 AC: 271AN: 152088Hom.: 1 Cov.: 31
GnomAD3 genomes
AF:
AC:
271
AN:
152088
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000394 AC: 86AN: 218010Hom.: 0 AF XY: 0.000306 AC XY: 36AN XY: 117706
GnomAD3 exomes
AF:
AC:
86
AN:
218010
Hom.:
AF XY:
AC XY:
36
AN XY:
117706
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000158 AC: 227AN: 1435528Hom.: 1 Cov.: 30 AF XY: 0.000130 AC XY: 93AN XY: 712684
GnomAD4 exome
AF:
AC:
227
AN:
1435528
Hom.:
Cov.:
30
AF XY:
AC XY:
93
AN XY:
712684
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00177 AC: 270AN: 152206Hom.: 1 Cov.: 31 AF XY: 0.00171 AC XY: 127AN XY: 74410
GnomAD4 genome
AF:
AC:
270
AN:
152206
Hom.:
Cov.:
31
AF XY:
AC XY:
127
AN XY:
74410
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CASP14-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 17, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at